Funded by the National Institutes of Health, the study will explore if telemedicine can deliver care that is equivalent to being seen by a physician in person for patients with eczema.
The study, which is being led by April Armstrong, MD, will evaluate 300 patients with atopic dermatitis. Dr. Armstrong and her team will determine if telemedicine helps these patients improve access to care, disease severity and quality of life while also reducing costs.
To conduct the study, Keck School of Medicine teamed up with Science 37. Per the agreement, Dr. Armstrong will leverage the Nora platform from Science 37, which is designed to operationalize virtual studies.
More articles on telehealth:
UCLA receives $28M to study opioid addiction telehealth treatments
The value of telehealth and digital health: Key thoughts from Stanford Children’s CMIO Natalie Pageler
Oklahoma State University leverages telemedicine to treat opioid addiction
